FDA Approved: SITAGLIPTIN AND METFORMIN HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a fixed-dose combination of sitagliptin and metformin hydrochloride under an Original Application from Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Sitagliptin and metformin hydrochloride (Sitagliptin and metformin hydrochloride)

Snippet

ORIG AP for SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (SITAGLIPTIN AND METFORMIN HYDROCHLORIDE)